{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:36:03Z","timestamp":1787319363530,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,3]],"date-time":"2017-01-03T00:00:00Z","timestamp":1483401600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajconline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.amjcard.2016.11.066","type":"journal-article","created":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T13:02:17Z","timestamp":1483707737000},"page":"1111-1115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Cardiovascular Safety of Droxidopa in Patients With Symptomatic Neurogenic Orthostatic Hypotension"],"prefix":"10.1016","volume":"119","author":[{"given":"William B.","family":"White","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald J.","family":"Rowse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Ziemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Arthur","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2016.11.066_bib1","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1212\/01.wnl.0000335246.93495.92","article-title":"The arterial baroreflex: functional organization and involvement in neurologic disease","volume":"71","author":"Benarroch","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.amjcard.2016.11.066_bib2","first-page":"256","article-title":"Mechanisms underlying the relationships between cardiovascular dysfunction and fall susceptibility in older adults","volume":"22","author":"Shaw","year":"2012","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.amjcard.2016.11.066_bib3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/HYPERTENSIONAHA.114.04035","article-title":"Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa","volume":"65","author":"Biaggioni","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.amjcard.2016.11.066_bib4","first-page":"57","article-title":"Droxidopa in patients with neurogenic orthostatic hypotension associated with Parkinson's disease (NOH306A)","volume":"4","author":"Hauser","year":"2014","journal-title":"J\u00a0Parkinsons Dis"},{"key":"10.1016\/j.amjcard.2016.11.066_bib5","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/mds.26086","article-title":"Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson's disease (NOH306B)","volume":"30","author":"Hauser","year":"2015","journal-title":"Mov Disord"},{"key":"10.1016\/j.amjcard.2016.11.066_bib6","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1212\/WNL.0000000000000615","article-title":"Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial","volume":"83","author":"Kaufmann","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.amjcard.2016.11.066_bib7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/WNF.0000000000000168","article-title":"Droxidopa and reduced falls in a trial of Parkinson patients with neurogenic orthostatic hypotension","volume":"39","author":"Hauser","year":"2016","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.amjcard.2016.11.066_bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1161\/HYPERTENSIONAHA.110.151654","article-title":"Orthostatic hypotension is a more robust predictor of cardiovascular events than nighttime reverse dipping in elderly","volume":"56","author":"Fagard","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.amjcard.2016.11.066_bib9","first-page":"101","article-title":"Mortality and prognosis in patients with neurogenic orthostatic hypotension","volume":"27","author":"Maule","year":"2012","journal-title":"Funct Neurol"},{"key":"10.1016\/j.amjcard.2016.11.066_bib10","series-title":"Full Prescribing Information","first-page":"1","year":"2014"},{"key":"10.1016\/j.amjcard.2016.11.066_bib11","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1161\/01.CIR.101.23.2710","article-title":"Sympathetically mediated hypertension in autonomic failure","volume":"101","author":"Shannon","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2016.11.066_bib12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10286-015-0324-8","article-title":"Clinical characteristics of supine hypertension in de novo Parkinson disease","volume":"26","author":"Umehara","year":"2016","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.amjcard.2016.11.066_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1681\/ASN.V10135","article-title":"Contrasting effects of vasodilators on blood pressure and sodium balance in the hypertension of autonomic failure","volume":"10","author":"Jordan","year":"1999","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.amjcard.2016.11.066_bib14","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0140-6736(99)05320-9","article-title":"Hypertensive cardiovascular damage in patients with primary autonomic failure","volume":"355","author":"Vagaonescu","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2016.11.066_bib15","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1161\/HYPERTENSIONAHA.115.05913","article-title":"Cardiac organ damage and arterial stiffness in autonomic failure: comparison with essential hypertension","volume":"66","author":"Milazzo","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.amjcard.2016.11.066_bib16","first-page":"751","article-title":"Safety and durability of effect with long-term, open-label droxidopa treatment in patients with symptomatic neurogenic orthostatic hypotension (NOH303)","volume":"6","author":"Isaacson","year":"2016","journal-title":"J\u00a0Parkinsons Dis"},{"key":"10.1016\/j.amjcard.2016.11.066_bib17","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jash.2016.07.010","article-title":"Long-term safety of droxidopa in patients with symptomatic neurogenic orthostatic hypotension","volume":"10","author":"Isaacson","year":"2016","journal-title":"J\u00a0Am Soc Hypertens"},{"key":"10.1016\/j.amjcard.2016.11.066_bib18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/eurheartj\/ehp329","article-title":"Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmo Preventive Project)","volume":"31","author":"Fedorowski","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2016.11.066_bib19","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/eurheartj\/ehm209","article-title":"Cardiovascular safety of drugs not intended for cardiovascular use: need for a new conceptual basis for assessment and approval","volume":"28","author":"Borer","year":"2007","journal-title":"Eur Heart J"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914916320203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914916320203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T18:13:46Z","timestamp":1658340826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914916320203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0002914916320203"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2016.11.066","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular Safety of Droxidopa in Patients With Symptomatic Neurogenic Orthostatic Hypotension","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2016.11.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}